Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Stephens

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Cancer Discovery|April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung CancerKartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.
Nature Genetics|April 29, 2008
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingPeter J Campbell, Philip J Stephens, Erin D Pleasance, et al.
Nature|October 29, 2010
The patterns and dynamics of genomic instability in metastatic pancreatic cancerPeter J Campbell, Shinichi Yachida, Laura J Mudie, et al.
Cancer Research|January 11, 2017
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor SpectraJuliann Chmielecki, Mark Bailey, Jie He, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Journal of the National Cancer Institute|January 26, 2018
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal CancerFilippo Pietrantonio, Federica Di Nicolantonio, Alexa B Schrock, et al.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Nature Medicine|February 14, 2012
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsiesDoron Lipson, Marzia Capelletti, Roman Yelensky, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Cancer Discovery|April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung CancerKartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.
Nature Genetics|April 29, 2008
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencingPeter J Campbell, Philip J Stephens, Erin D Pleasance, et al.
Nature|October 29, 2010
The patterns and dynamics of genomic instability in metastatic pancreatic cancerPeter J Campbell, Shinichi Yachida, Laura J Mudie, et al.
Cancer Research|January 11, 2017
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor SpectraJuliann Chmielecki, Mark Bailey, Jie He, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Journal of the National Cancer Institute|January 26, 2018
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal CancerFilippo Pietrantonio, Federica Di Nicolantonio, Alexa B Schrock, et al.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Nature Medicine|February 14, 2012
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsiesDoron Lipson, Marzia Capelletti, Roman Yelensky, et al.
Pageof 17